DDC and Parkinson disease: Stalevo is an anti-parkinsonian dopaminergic combination medication that contains carbidopa, levodopa, and entacapone for the treatment of Parkinson's disease.Carbidopa inhibits aromatic-L-amino-acid decarboxylase (DOPA Decarboxylase or DDC).